J&J scraps late-stage study testing Stelara for lupus

J&J scraps late-stage study testing Stelara for lupus

Source: 
Reuters
snippet: 

Johnson & Johnson’s Janssen unit said on Friday it would discontinue a late-stage study testing its psoriatic arthritis drug Stelara as a treatment for lupus as it was not found to be effective against the auto-immune disease.